FR2070177A1 - - Google Patents

Info

Publication number
FR2070177A1
FR2070177A1 FR7039077A FR7039077A FR2070177A1 FR 2070177 A1 FR2070177 A1 FR 2070177A1 FR 7039077 A FR7039077 A FR 7039077A FR 7039077 A FR7039077 A FR 7039077A FR 2070177 A1 FR2070177 A1 FR 2070177A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7039077A
Other languages
French (fr)
Other versions
FR2070177B1 (de
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith Kline and French Laboratories Ltd
GlaxoSmithKline LLC
Original Assignee
Smith Kline and French Laboratories Ltd
GlaxoSmithKline LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline and French Laboratories Ltd, GlaxoSmithKline LLC filed Critical Smith Kline and French Laboratories Ltd
Publication of FR2070177A1 publication Critical patent/FR2070177A1/fr
Application granted granted Critical
Publication of FR2070177B1 publication Critical patent/FR2070177B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR7039077A 1969-10-29 1970-10-29 Expired FR2070177B1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5289069 1969-10-29

Publications (2)

Publication Number Publication Date
FR2070177A1 true FR2070177A1 (de) 1971-09-10
FR2070177B1 FR2070177B1 (de) 1974-10-11

Family

ID=10465720

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7039077A Expired FR2070177B1 (de) 1969-10-29 1970-10-29

Country Status (9)

Country Link
JP (1) JPS4917262B1 (de)
BE (1) BE758145A (de)
CA (1) CA953725A (de)
DE (1) DE2052692A1 (de)
FR (1) FR2070177B1 (de)
GB (1) GB1296544A (de)
IE (1) IE34665B1 (de)
SE (1) SE390303B (de)
ZA (1) ZA707150B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA938556A (en) * 1970-06-25 1973-12-18 Smith Kline And French Laboratories Limited Pharmaceutical compositions containing thiourea derivatives
GB1338169A (en) * 1971-03-09 1973-11-21 Smith Kline French Lab Ureas thioureas and guanidines
GB1397436A (en) * 1972-09-05 1975-06-11 Smith Kline French Lab Heterocyclic n-cyanoguinidines
NZ186965A (en) 1977-04-20 1980-02-21 Ici Ltd Guanidino derivatives and pharmaceutical compositions
US4262125A (en) * 1979-07-23 1981-04-14 American Home Products Corporation (1H-Imidazol-5-ylmethyl)isothioureas
IT1201523B (it) * 1982-05-18 1989-02-02 Angeli Inst Spa Eterociclilfenilfomramidine,processi per la loro preparazione e loro uso farmaceutico
US4520025A (en) * 1982-07-21 1985-05-28 William H. Rorer, Inc. Bicyclic nitrogen heterocyclic ethers and thioethers, and their pharmaceutical uses
FR2660862B1 (fr) * 1990-04-13 1994-09-23 Bioprojet Soc Civ Application therapeutique de derives de l'histamine, nouveau derive de l'histamine et utilisation de ces derives pour la preparation de medicaments.
US5321039A (en) * 1990-04-13 1994-06-14 Societe Civile Bioprojet Method of inducing a histamine agonist action on H2 receptors
NL9100365A (nl) * 1991-02-27 1992-09-16 Seed Capital Investments Imidazoolderivaten met agonistische of antagonistische activiteit op de histamine h3-receptor.
AU662135B2 (en) * 1991-02-27 1995-08-24 Seed Capital Investments (Sci) B.V. Imidazole-derivatives having agonistic or antagonistic activity on the histamine H3-receptor
GB0404434D0 (en) * 2004-02-27 2004-03-31 Novartis Ag Organic compounds

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2548746A (en) * 1947-10-10 1951-04-10 Sharp & Dohme Inc S-(4-thiazolylmethyl)-isothioureas
BE683796A (de) * 1965-07-07 1967-01-09

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2548746A (en) * 1947-10-10 1951-04-10 Sharp & Dohme Inc S-(4-thiazolylmethyl)-isothioureas
BE683796A (de) * 1965-07-07 1967-01-09

Also Published As

Publication number Publication date
DE2052692A1 (de) 1971-05-06
GB1296544A (de) 1972-11-15
SE390303B (sv) 1976-12-13
CA953725A (en) 1974-08-27
JPS4917262B1 (de) 1974-04-27
FR2070177B1 (de) 1974-10-11
IE34665B1 (en) 1975-07-09
BE758145A (fr) 1971-04-28
IE34665L (en) 1971-04-29
ZA707150B (en) 1971-07-28

Similar Documents

Publication Publication Date Title
AU2270770A (de)
AU429630B2 (de)
FR2070177B1 (de)
AU2355770A (de)
AU442375B2 (de)
AU427401B2 (de)
AU442322B2 (de)
AU438128B2 (de)
AU410358B2 (de)
AU442357B2 (de)
AU428131B2 (de)
AU428129B2 (de)
AU414607B2 (de)
AU442285B2 (de)
AU428074B2 (de)
AU442380B2 (de)
AU425297B2 (de)
AU442463B2 (de)
AU417208B2 (de)
CH562164A5 (de)
CH545802A (de)
BG19075A3 (de)
BE760202A (de)
BE758243A (de)
BE754706R (de)

Legal Events

Date Code Title Description
ST Notification of lapse